Exact Sciences plans to conduct a public offering of its common stock

Bookrunner Baird, co-manager William Blair help fund working capital

By Devika Patel

Knoxville, Tenn., Dec. 5 - Exact Sciences Corp. plans to price a public sale of its common stock, according to a prospectus supplement filed Monday with the Securities and Exchange Commission.

The deal has a 30-day greenshoe.

Robert W. Baird & Co. Inc. is the bookrunning manager. William Blair & Co. is co-manager.

Proceeds will be used for general corporate and working capital purposes, including product development and efforts to obtain FDA clearance of the company's colorectal cancer screening product and product commercialization activities.

Exact Sciences, based in Marlborough, Mass., develops screening technologies for cancer detection.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.